A. Knuth

1.8k total citations
33 papers, 816 citations indexed

About

A. Knuth is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, A. Knuth has authored 33 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in A. Knuth's work include Immunotherapy and Immune Responses (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and T-cell and B-cell Immunology (6 papers). A. Knuth is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and T-cell and B-cell Immunology (6 papers). A. Knuth collaborates with scholars based in Germany, United States and Switzerland. A. Knuth's co-authors include Lloyd J. Old, Herbert F. Oettgen, Thierry Boon, M. Hérin, Cendrine Lemoine, Aline Van Pel, P. Weynants, René Devos, K. H. Meyer zum Büschenfelde and Julia Karbach and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

A. Knuth

30 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Knuth Germany 12 536 344 256 107 102 33 816
I G Schmidt-Wolf Germany 13 636 1.2× 653 1.9× 190 0.7× 28 0.3× 79 0.8× 24 1.0k
Ilia N. Buhtoiarov United States 15 614 1.1× 409 1.2× 164 0.6× 100 0.9× 36 0.4× 30 812
Felix Klug Germany 8 616 1.1× 650 1.9× 192 0.8× 148 1.4× 181 1.8× 8 1.0k
Sissel Trachsel Norway 8 335 0.6× 412 1.2× 311 1.2× 29 0.3× 74 0.7× 8 732
Jolie Snively United States 7 630 1.2× 682 2.0× 276 1.1× 62 0.6× 71 0.7× 8 934
Akihiro Hosoi Japan 16 592 1.1× 568 1.7× 236 0.9× 71 0.7× 158 1.5× 30 928
Kenneth F. May United States 12 899 1.7× 667 1.9× 168 0.7× 100 0.9× 41 0.4× 16 1.1k
Dennis Knapp United States 9 284 0.5× 269 0.8× 398 1.6× 48 0.4× 71 0.7× 11 694
Lekh N. Dahal United Kingdom 15 409 0.8× 258 0.8× 203 0.8× 196 1.8× 42 0.4× 32 675
W.E. Gillanders United States 5 493 0.9× 826 2.4× 231 0.9× 69 0.6× 145 1.4× 6 1.0k

Countries citing papers authored by A. Knuth

Since Specialization
Citations

This map shows the geographic impact of A. Knuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Knuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Knuth more than expected).

Fields of papers citing papers by A. Knuth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Knuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Knuth. The network helps show where A. Knuth may publish in the future.

Co-authorship network of co-authors of A. Knuth

This figure shows the co-authorship network connecting the top 25 collaborators of A. Knuth. A scholar is included among the top collaborators of A. Knuth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Knuth. A. Knuth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lennerz, Volker, Elisa Gallerani, Cristiana Sessa, et al.. (2011). First-in-human trial focusing on the immunologic effects of the survivin-derived multiepitope vaccine EMD640744.. Journal of Clinical Oncology. 29(15_suppl). 2515–2515. 2 indexed citations
2.
Boehmer, Lotta von, Peter J. Wild, Laura Keller, et al.. (2009). Cancer testis antigen expression and immune responses by prostate cancer patients: Implications for prognosis and immunotherapy. Journal of Clinical Oncology. 27(15_suppl). e16101–e16101. 1 indexed citations
3.
Samaras, Panagiotis, et al.. (2007). Treatment of POEMS syndrome with bevacizumab. Haematologica. 92(10). 1438–1439. 53 indexed citations
4.
Al-Batran, Salah-Eddin, Akin Atmaca, D.H.J. Jager, et al.. (2004). Dose Escalation Study for Defining the Maximum Tolerated Dose of Continuous Oral Trofosfamide in Pretreated Patients with Metastatic Lung Cancer. Oncology Research and Treatment. 27(6). 534–538. 3 indexed citations
5.
Atmaca, Akin, Alexander Maurer, Thorsten Heinzel, et al.. (2004). A dose-escalating phase I study with valproic acid (VPA) in patients (pts) with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 3169–3169. 3 indexed citations
6.
Köhne, C.-H., Raphael Catane, B. Klein, et al.. (2003). Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial. British Journal of Cancer. 89(6). 997–1001. 78 indexed citations
7.
Mischo, Axel, Andreas Wadle, Dirk Jäger, et al.. (2003). Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.. PubMed. 3. 5–5. 37 indexed citations
8.
Jäger, Dirk, Elke Jäger, Fabrizio Bert, & A. Knuth. (2001). Cellular and humoral immune responses of cancer patients to defined tumor antigens.. PubMed. 19. 385–93. 3 indexed citations
9.
Ganser, Arnold, W.-K. Hofmann, Oliver G. Ottmann, et al.. (1997). 174 Intensive chemotherapy (idarubicin, ARA-C, VP-16) combined with G-CSF-priming yields high remission rates in patients with advanced MDS and high-risk AML. Leukemia Research. 21(1). S46–S46. 1 indexed citations
10.
Maeurer, Markus, Julia Karbach, Russell D. Salter, et al.. (1996). Amino acid substitutions at position 97 in HLA‐A2 segregate cytolysis from cytokine release in MART‐1/Melan‐A peptide AAGIGILTV‐specific cytotoxic T lymphocytes. European Journal of Immunology. 26(11). 2613–2623. 6 indexed citations
11.
Bernhard, H., Markus Maeurer, Elke Jäger, et al.. (1996). Recognition of Human Renal Cell Carcinoma and Melanoma by HLA‐A2‐Restricted Cytotoxic T Lymphocytes is Mediated by Shared Peptide Epitopes and Up‐Regulated by Interferon‐γ. Scandinavian Journal of Immunology. 44(3). 285–292. 22 indexed citations
12.
Thatcher, Nicholas, Jacques De Grève, David Cunningham, et al.. (1995). A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma. European Journal of Cancer. 31(13-14). 2157–2163. 12 indexed citations
13.
Bernhard, H., et al.. (1993). Combination 5-fluorouracil (FU), folinic acid (FA) and alpha-interferon 28 (IFN) in advanced gastric cancer. European Journal of Cancer. 29. S101–S101. 3 indexed citations
14.
Herrmann, Richard, et al.. (1992). Sequential methotrexate and 5-fluorouracil (FU) vs. FU alone in metastatic colorectal cancer. Annals of Oncology. 3(7). 539–543. 15 indexed citations
15.
Knuth, A.. (1991). [Therapy of inoperable cancers of the exocrine pancreas and liver].. PubMed. 26. 219–219. 1 indexed citations
16.
Dippold, Wolfgang, Hans‐Peter Dienes, Reinhard Klingel, et al.. (1987). Signet ring stomach cancer: Morphological characterization and antigenic profile of a newly established cell line (Mz-Sto-1). European Journal of Cancer and Clinical Oncology. 23(6). 697–706. 23 indexed citations
17.
Hermann, Robert Michael, et al.. (1986). Randomized multicenter trial of sequential methotrexate (MTX) and 5-Fluorouracil (FU) vs FU alone in metastatic colorectal carcinoma (CRC). Journal of Cancer Research and Clinical Oncology. 111(S1). S94–S94. 6 indexed citations
18.
Knuth, A., et al.. (1984). T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.. Proceedings of the National Academy of Sciences. 81(11). 3511–3515. 181 indexed citations
19.
Knuth, A., Kenneth O. Lloyd, Mack Lipkin, Herbert F. Oettgen, & Lloyd J. Old. (1983). Natural antibodies in human sera directed against blood‐group‐related determinants expressed on colon cancer cells. International Journal of Cancer. 32(2). 199–204. 9 indexed citations
20.
Wagner, P. K., et al.. (1982). An in vitro model for the study of human parathyroid gland tissue: Single cell suspensions and monolayer cultures. Research in Experimental Medicine. 181(2). 147–154. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I G Schmidt-Wolf Breakdown of academic impact, for papers by Ilia N. Buhtoiarov Breakdown of academic impact, for papers by Felix Klug Breakdown of academic impact, for papers by Sissel Trachsel Breakdown of academic impact, for papers by Jolie Snively Breakdown of academic impact, for papers by Akihiro Hosoi Breakdown of academic impact, for papers by Kenneth F. May Breakdown of academic impact, for papers by Dennis Knapp Breakdown of academic impact, for papers by Lekh N. Dahal Breakdown of academic impact, for papers by W.E. Gillanders
Rankless by CCL
2026